About Genezen
Genezen is a Healthcare company based in Indianapolis (United States) founded in 2014. CDMO focused on manufacturing of viral vector products. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Cell and Gene Therapy. Its legal entity in India is Genezen Phamaceuticals Private Limited (U74999MH2011PTC217289). Its competitors include VectorBuilder, Oxford Biomedica Solutions and Ascend; 2 of its 3 listed competitors have raised funding.
Company details
Genezen was founded in 2014 and is headquartered in Indianapolis, United States. Operations are centered in the biotechnology sector, where contract development and manufacturing services for viral vector products are offered. These services support gene therapy applications and related biopharmaceutical needs. Focus is placed on scalable production processes to meet client requirements in the viral vector space.
- Headquarters Indianapolis, United States
- SectorsHealthcare
- Website genezen.com
- Social LinkedIn X
- Legal Name Genezen Phamaceuticals Private Limited
- Date of Incorporation 10 May, 2011
- Jurisdiction Thane, Maharashtra, India
- Investors
Associated legal entities of Genezen
Genezen operates through Genezen Phamaceuticals Private Limited (strike off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Genezen Phamaceuticals Private Limited CIN U74999MH2011PTC217289 | Strike Off | 10 May 2011 | Thane, Maharashtra | 2 | View details |
Funding Insights of Genezen
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Genezen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | Seed | – | Ampersand Capital | – |
1 investors in total: 1 institutional.
Investors in Genezen
Genezen has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Ampersand Capital Partners is focused on investments in healthcare and life sciences. | ampersandcapital.com | Boston, United States |
Investor details for Genezen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Genezen Phamaceuticals Private Limited (Genezen)
Genezen Phamaceuticals Private Limited is the primary company behind Genezen. The board of Genezen Phamaceuticals Private Limited currently have 2 directors; the longest-serving is Burhani Shabbir Rangwala, appointed in 2011. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Burhani Shabbir Rangwala DIN 03482643 | Director | 10 May 2011 | 15 yrs 5 mo | Genezen Phamaceuticals Private Limited |
| Khadija Burhani Rangwala DIN 03482610 | Director | 10 May 2011 | 15 yrs 5 mo | Genezen Phamaceuticals Private Limited |
Timeline of Genezen
2 dated milestones of Genezen across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Genezen is founded.
- Funding First funding round.
Competitors of Genezen
Genezen has 3 listed competitors in our database, 2 of them funded. They include VectorBuilder, Oxford Biomedica Solutions and Ascend.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| vectorbuilder.com | 2014 | Chicago, United States | $57.15M | Custom vector design, cloning, and virus packaging are offered online. | ||
| oxbsolutions.com | 2022 | Bedford, United States | Oxford Biomedica Solutions is a CDMO focused on manufacturing AAV cell and gene therapy products. | |||
| useascend.com | 2021 | Palo Alto, United States | $35.5M | 39 | Online insurance payments and premium financing are enabled for businesses. |
Detailed competitors of Genezen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Genezen
The website of Genezen (genezen.com) receives about 4.1K visits a month.
- Monthly visits4.1K
▲ 8.6% vs previous month
Websites whose visitors overlap most with Genezen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pharmaindustrial-india.com | 100% | #4,026,656 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Genezen (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genezen
Complete news archive for Genezen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genezen
Genezen was founded in 2014 and raised its 1st funding round 7 years after it was founded.
Genezen is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
Genezen was founded in 2014 and is headquartered in Indianapolis, United States. Operations are centered in the biotechnology sector, where contract development and manufacturing services for viral vector products are offered. These services support gene therapy applications and related biopharmaceutical needs. Focus is placed on scalable production processes to meet client requirements in the viral vector space.
Genezen's top competitors include VectorBuilder, Ascend and Oxford Biomedica Solutions.
Genezen has 1 investor. Key investors include Ampersand Capital Partners.
Genezen operates through Genezen Phamaceuticals Private Limited.
The legal entities of Genezen currently have 2 directors, including Burhani Shabbir Rangwala, Khadija Burhani Rangwala.